Abstract
Background: Unconventional Knoevenagel-type indoles have been the topic of interest of many synthetic chemists because of its promising efficacy in different diseases including cancer.
Objective: To explore the structural requirements of Knoevenagel-type cytotoxic indoles for higher efficacy.
Methods: Multi-QSAR modeling (MLR, ANN, SVM, Bayesian classification, HQSAR and Topomer CoMFA) was performed on these analogs.
Results: All these modeling techniques were validated individually and interpreted with the experimental SAR observations. Phenyl or p-methoxyphenyl substitution at 2nd position, electron withdrawing groups (such as sulphonyl, cyano etc.) at 3rd position and methoxy substation at 5th position of the indole scaffold may favor cytotoxicity. Eight new indole molecules were predicted from the developed QSAR models.
Conclusion: These newly designed compounds may bind to the colchicine binding site of the tubulin protein as suggested by the molecular docking study.
Keywords: Knoevenagel-type indoles, cytotoxic agents, ANN, SVM, Bayesian classification model, HQSAR, Topomer CoMFA, molecular docking.
Graphical Abstract
Current Computer-Aided Drug Design
Title:An Integrated Multi-QSAR Modeling Approach for Designing Knoevenagel- Type Indoles with Enhancing Cytotoxic Profiles
Volume: 13 Issue: 4
Author(s): Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha*Shovanlal Gayen*
Affiliation:
- Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, P.O. Box 17020, Jadavpur University, Kolkata 700032, (WB),India
- Laboratory of Drug Design and Discovery, Department of Pharmaceutical Sciences, Dr. Harisingh Gour University (A Central University), Sagar 470003, (MP),India
Keywords: Knoevenagel-type indoles, cytotoxic agents, ANN, SVM, Bayesian classification model, HQSAR, Topomer CoMFA, molecular docking.
Abstract: Background: Unconventional Knoevenagel-type indoles have been the topic of interest of many synthetic chemists because of its promising efficacy in different diseases including cancer.
Objective: To explore the structural requirements of Knoevenagel-type cytotoxic indoles for higher efficacy.
Methods: Multi-QSAR modeling (MLR, ANN, SVM, Bayesian classification, HQSAR and Topomer CoMFA) was performed on these analogs.
Results: All these modeling techniques were validated individually and interpreted with the experimental SAR observations. Phenyl or p-methoxyphenyl substitution at 2nd position, electron withdrawing groups (such as sulphonyl, cyano etc.) at 3rd position and methoxy substation at 5th position of the indole scaffold may favor cytotoxicity. Eight new indole molecules were predicted from the developed QSAR models.
Conclusion: These newly designed compounds may bind to the colchicine binding site of the tubulin protein as suggested by the molecular docking study.
Export Options
About this article
Cite this article as:
Amin Abdul Sk. , Adhikari Nilanjan , Jha Tarun *, Gayen Shovanlal *, An Integrated Multi-QSAR Modeling Approach for Designing Knoevenagel- Type Indoles with Enhancing Cytotoxic Profiles, Current Computer-Aided Drug Design 2017; 13 (4) . https://dx.doi.org/10.2174/1573409913666170309150014
DOI https://dx.doi.org/10.2174/1573409913666170309150014 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Silico Ligand-Receptor Docking of Potentially Selective Butyrylcholinesterase Inhibitors Structurally Related to the Marine Natural Product Debromoflustramine B
Medicinal Chemistry Recent Updates on Molecular Genetic Engineering Approaches and Applications of Human Therapeutic Proteins
Current Protein & Peptide Science Status Epilepticus: An Overview
Current Drug Metabolism Auto-Contractive Maps: An Artificial Adaptive System for Data Mining. An Application to Alzheimer Disease
Current Alzheimer Research Hypodopaminergia and “Precision Behavioral Management” (PBM): It is a Generational Family Affair
Current Pharmaceutical Biotechnology Pharmacological Modulation of the State of Awareness in Patients with Disorders of Consciousness: An Overview
Current Pharmaceutical Design Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design Autoinflammation and Immunomodulation in Inflammatory Fibromyalgia Syndrome- A Review
Current Rheumatology Reviews Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia
Current Topics in Medicinal Chemistry Evaluation of Trypanocidal and Antioxidant Activities of a Selected Series of 3-amidocoumarins
Medicinal Chemistry Communication of Suicidality via Social Media
Adolescent Psychiatry Target Prediction of Small Molecules with Information of Key Molecular Interactions
Current Topics in Medicinal Chemistry Microvascular Diseases: Is A New Era Coming?
Cardiovascular & Hematological Agents in Medicinal Chemistry Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder
Current Neuropharmacology Blood Pressure and White Matter Lesions in Patients with Vascular Disease: The SMART-MR Study
Current Neurovascular Research Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases
Current Alzheimer Research Large-Scale Purification of Human BACE Expressed in Mammalian Cells and Removal of the Prosegment with HIV-1 Protease to Improve Crystal Diffraction
Protein & Peptide Letters Alzheimers Disease and Immunotherapy
Current Alzheimer Research